Session 13: Epidemiology, Informatics, Population Health, Health Outcomes

Chair(s)

• 

  Nadia Hindi, MD

  Medical Oncologist
  Fundacion Jimenez Diaz University Hospital/HG Villalba and Instituto de Investigaciones Sanitarias Fundación Jimenez Diaz
  Madrid, Madrid, Spain

Moderator(s)

• 

  Abha Gupta, MD, MSc, FRCPC (she/her/hers)

  Dr.
  Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Ontario, Canada; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada; CanSaRCC, Princess Margaret Cancer Center, Ontario, Canada
  Toronto, Ontario, Canada
• 

  Jyoti Bajpai, MD DM (she/her/hers)

  Professor
  Tata Memorial Centre
  Mumbai, Maharashtra, India

Presentations:

• 2:00 PM – 2:08 PM

  DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
  

  Author: Linus Lee, BE – Rush University Medical Center

  Co-Author: Gayathri Vijayakumar, BS – Rush University Medical Center

  Co-Author: Thomas Yi, N/A, BS – Rush University Medical Center

  Co-Author: Michael P. Fice, MD – Rush University Medical Center

  Co-Author: Conor Jones, MD – Rush University Medical Center

  Co-Author: Evan Klein, BS, BA (he/him/his) – Rush Medical College

  Co-Author: Neil Buac, BS (he/him/his) – Rush University Medical Center

  Co-Author: Matthew W. Colman, MD – Rush University Medical Center

  Co-Author: Steven Gitelis, MD – Rush University Medical Center

  Co-Author: Alan T. Blank, MD, MS – Rush University Medical Center
• 2:08 PM – 2:16 PM

  DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
  

  Author: Meena Bedi, MD, MS – Medical College of Wisconsin

  Co-Author: John Neilson, N/A, MD – Medical College of Wisconsin

  Co-Author: Thuy Tran, N/A, MD – City of Hope

  Co-Author: George Poultsides, N/A, MD – Stanford

  Co-Author: Jennifer Tseng, N/A, MD – University of Chicago

  Co-Author: Kevin Roggin, N/A, MD – University of Chicago

  Co-Author: Konstantinos Votanopoulos, N/A, MD – Wake Forest

  Co-Author: Bradley Krasnick, N/A, MD – Washington University

  Co-Author: Kenneth Cardona, MD, FACS – Winship Cancer Institute, Emory University

  Co-Author: David M. King, MD – Medical College of Wisconsin
• 2:16 PM – 2:24 PM

  NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
  

  Co-Author: Sarah E. Lindsay, MD (she/her/hers) – Oregon Health & Science University

  Co-Author: Yee Doung, MD (she/her/hers) – Oregon Health & Science University

  Co-Author: Cecelia Madison, MBI (she/her/hers) – Portland VA Medical Center

  Co-Author: James Hayden, MD, PhD (he/him/his) – Oregon Health & Science University

  Author: Kenneth R. Gundle, MD (he/him/his) – Oregon Health & Science University | Portland VA Medical Center
• 2:24 PM – 2:32 PM

  MEANINGFUL INTERPRETATION OF TORONTO EXTREMITY SALVAGE SCORE IN PEOPLE WITH SOFT-TISSUE SARCOMA USING RASCH ANALYSIS
  

  Author: Kedar Mate, PhD – McGill University Health Centre

  Co-Author: robert turcotte, MD (he/him/his) – McGill University Health Centre

  Co-Author: Jose Iturregui, MD – Mayo Clinic

  Co-Author: Nancy Mayo, PhD – McGill University Health Centre

  Co-Author: Krista Goulding, N/A, MD, MPH – Department of Orthopedic Surgery, Mayo Clinic
• 2:32 PM – 2:40 PM

  POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
  

  Author: Raza Sayyed, FRCSEd, EBSQ (Surg Onc) – The Royal Marsden Hospital

  Co-Author: Joseph Morilla, N/A, n/a – The Royal Marsden Hospital

  Co-Author: Vaia Rompou, N/A, n/a – The Royal Marsden Hospital

  Co-Author: Shane H. Zaidi, MD – The Royal Marsden Hospital

  Co-Author: Aisha B. Miah, BMedSci MBBS MRCP FRCR PhD – The Royal Marsden NHS Foundation Trust

  Co-Author: Khin Thway, MD – The Royal Marsden NHS Foundation Trust

  Co-Author: David J. Coker, MD; LLB/BSc; MSurgEd; FRACS – The Royal Marsden Hospital

  Co-Author: Laura Aggenbach, MRCS RCS Eng. – The Royal Marsden Hospital

  Co-Author: Jonathan Hannay, n/a – The Royal Marsden Hospital

  Co-Author: Myles JF Smith, MB BCh BAO, PhD, FRCSI, FRCS – Sarcoma Unit, Royal Marsden Hospital

  Co-Author: Andrew J. Hayes, MD PhD – Royal Marsden Hospital

  Co-Author: Christina Messiou, MRCP, FRCS, MD(Res) – The Royal Marsden NHS Trust

  Co-Author: Christian Kelly-Morland, FRCR MBBS – The Royal Marsden Hospital

  Co-Author: Charlotte Benson, MD (she/her/hers) – The Royal Marsden NHS Foundation Trust

  Co-Author: Robin L. Jones, N/A, MD, PhD – The Royal Marsden NHS Foundation Trust

  Co-Author: Dirk Strauss, MMed, FCS, FRCS – Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust
• 2:40 PM – 2:48 PM

  PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
  

  Author: Feng Lin, PhD – Daiichi Sankyo, Inc.

  Co-Author: Winghan Jackie Kwong, PharmD, PhD (she/her/hers) – Daiichi Sankyo, Inc.

  Co-Author: Irene Pan, MS – United BioSource LLC

  Co-Author: Xin Ye, PhD – Daiichi Sankyo, Inc., Basking Ridge, NJ, USA

  Co-Author: Dong Dai, PhD, MBA – Daiichi Sankyo, Inc.

  Co-Author: William D. Tap, MD – Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
• 2:48 PM – 3:00 PM

  Q&A